The five patients from the subgroup with known mutations had either HAE due to mutations in F12 gene (HAE-FXII) or HAE due to mutations in PLG gene (HAE-PLG), both of which are classified as bradykinin-mediated angioedema (AE-BK). This evidence concerns the gene PLG and hereditary angioedema.